Reduced rates of gene loss, gene silencing, and gene mutation in Dnmt1-deficient embryonic stem cells

Molecular and Cellular Biology
M F ChanPeter W Laird

Abstract

Tumor suppressor gene inactivation is a crucial event in oncogenesis. Gene inactivation mechanisms include events resulting in loss of heterozygosity (LOH), gene mutation, and transcriptional silencing. The contribution of each of these different pathways varies among tumor suppressor genes and by cancer type. The factors that influence the relative utilization of gene inactivation pathways are poorly understood. In this study, we describe a detailed quantitative analysis of the three major gene inactivation mechanisms for a model gene at two different genomic integration sites in mouse embryonic stem (ES) cells. In addition, we targeted the major DNA methyltransferase gene, Dnmt1, to investigate the relative contribution of DNA methylation to these various competing gene inactivation pathways. Our data show that gene loss is the predominant mode of inactivation of a herpes simplex virus thymidine kinase neomycin phosphotransferase reporter gene (HSV-TKNeo) at the two integration sites tested and that this event is significantly reduced in Dnmt1-deficient cells. Gene silencing by promoter methylation requires Dnmt1, suggesting that the expression of Dnmt3a and Dnmt3b alone in ES cells is insufficient to achieve effective gene s...Continue Reading

References

Dec 24, 1992·Cell·J C ShenP A Jones
Dec 1, 1991·Proceedings of the National Academy of Sciences of the United States of America·F SchwartzR Kucherlapati
Aug 11, 1991·Nucleic Acids Research·P W LairdA Berns
May 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·R L YenofskyJ W Pellow
Jun 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·J Sved, A Bird
Jan 1, 1988·Molecular Carcinogenesis·K A EckertN R Drinkwater
Jul 1, 1983·Analytical Biochemistry·A P Feinberg, B Vogelstein
Apr 1, 1984·Proceedings of the National Academy of Sciences of the United States of America·G M Church, W Gilbert
Jun 30, 1982·Biochimica Et Biophysica Acta·R Y WangM Ehrlich
Aug 1, 1994·Molecular and Cellular Biology·C L Hsieh
Apr 21, 1995·Cell·P W LairdR Jaenisch
Nov 14, 1995·Biochemistry·M J Yebra, A S Bhagwat
Mar 1, 1995·Mutagenesis·E G Lichtenauer-KaligisJ G Tasseron-de Jong
Jan 1, 1994·Human Molecular Genetics·P W Laird, R Jaenisch
Aug 11, 1994·Nucleic Acids Research·S J ClarkM Frommer
Mar 25, 1994·Nucleic Acids Research·J C ShenP A Jones
Oct 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·J WuS B Baylin
May 31, 1996·The Journal of Biological Chemistry·P NeddermannJ Jiricny
Feb 1, 1996·Chromosome Research : an International Journal on the Molecular, Supramolecular and Evolutionary Aspects of Chromosome Biology·M FredianiM R Castiglione
Jan 1, 1996·Annual Review of Genetics·P W Laird, R Jaenisch
Jan 21, 1997·Proceedings of the National Academy of Sciences of the United States of America·S RamchandaniM Szyf
Apr 1, 1997·Mutation Research·M L Gonzalgo, P A Jones
Apr 29, 1997·Proceedings of the National Academy of Sciences of the United States of America·L Jackson-GrusbyR Jaenisch
Oct 23, 1997·Mutation Research·W JiM Ehrlich
Jan 10, 1998·Trends in Genetics : TIG·S U KassA P Wolffe
Jan 27, 1998·Genes, Chromosomes & Cancer·A G de Nooij-van DalenM Giphart-Gassler

❮ Previous
Next ❯

Citations

Apr 5, 2002·Chembiochem : a European Journal of Chemical Biology·Albert Jeltsch
Jul 27, 2007·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·I Ibáñez de Cáceres, P Cairns
Sep 6, 2013·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Junghee LeeHoon Ryu
Oct 29, 2004·Nucleic Acids Research·Myungjin KimPeter W Laird
Mar 21, 2007·Molecular and Cellular Biology·Marc Damelin, Timothy H Bestor
Apr 10, 2002·Molecular and Cellular Biology·Binh N TrinhPeter W Laird
Sep 12, 2002·Biological Chemistry·Masahiko ShiraishiTakao Sekiya
May 26, 2009·Ageing Research Reviews·Alexander L Mazin
Jan 2, 2009·Neurobiology of Aging·Diego MastroeniJoseph Rogers
Aug 19, 2008·Mutation Research·Jared M Fischer, James R Stringer
Mar 28, 2013·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Luc GailhousteTakahiro Ochiya
Sep 8, 2004·Biochemical and Biophysical Research Communications·Kazue Tsuji-TakayamaKunzo Orita
Jun 15, 2015·Progress in Neurobiology·Roy LardenoijeBart P F Rutten
Oct 23, 2012·Cell Stem Cell·Li B LiDavid W Russell
Oct 13, 2007·Biochimica Et Biophysica Acta·Ezat SajediJuan Pedro Martinez-Barbera
Feb 6, 2017·Cold Spring Harbor Perspectives in Medicine·Angelo FortunatoJohn W Pepper
Apr 3, 2003·Nature Reviews. Cancer·Peter W Laird
Aug 3, 2002·Oncogene·Egor Prokhortchouk, Brian Hendrich
Aug 3, 2002·Oncogene·Melanie Ehrlich
Apr 6, 2005·Human Molecular Genetics·Peter W Laird
Jun 4, 2002·Nature Reviews. Genetics·Peter A Jones, Stephen B Baylin
Jun 14, 2005·Biochemistry. Biokhimii︠a︡·M Ehrlich
Jan 14, 2005·Journal of Cellular Physiology·Maria Irene ScaranoMaurizio D'Esposito
Jan 10, 2002·Genes & Development·Adrian Bird

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Epigenetics & Methyl-CpG (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. Here is the latest research on cancer epigenetics and methyl-CpG binding proteins including ZBTB38.

Cancer Epigenetics

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cell Signaling & Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. This feed covers the latest research on signaling and epigenetics in cell growth and cancer.

Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.

Cancer Epigenetics and Senescence (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may be involved in regulating senescence in cancer cells. This feed captures the latest research on cancer epigenetics and senescence.